Boehringer Ingelheim (Canada) Ltd./Ltée is operational in every province and territory in Canada, save its newest, Nunavut. In 2007, our Research & Development investments in Canada totaled almost $100 million. We employ over 700 people in all regions of the country and contribute both directly and indirectly towards significant public and private healthcare services.